Scarinci, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 808
EU - Europa 736
AS - Asia 125
SA - Sud America 3
Totale 1.672
Nazione #
US - Stati Uniti d'America 806
DE - Germania 234
SE - Svezia 160
IT - Italia 103
CN - Cina 66
UA - Ucraina 55
FR - Francia 47
IE - Irlanda 47
FI - Finlandia 32
IN - India 27
GB - Regno Unito 19
PL - Polonia 12
BE - Belgio 10
TR - Turchia 10
SG - Singapore 8
IR - Iran 6
NL - Olanda 3
RO - Romania 3
RU - Federazione Russa 3
BR - Brasile 2
ES - Italia 2
HK - Hong Kong 2
HU - Ungheria 2
MY - Malesia 2
PH - Filippine 2
AR - Argentina 1
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
IQ - Iraq 1
PK - Pakistan 1
PT - Portogallo 1
Totale 1.672
Città #
Chandler 222
Ashburn 73
New York 51
Dublin 45
San Mateo 43
Jacksonville 41
Marseille 20
Wilmington 20
Helsinki 19
Milan 19
Ann Arbor 18
Dearborn 18
Bremen 16
Houston 14
Nanjing 14
Nürnberg 13
Kraków 12
Lawrence 12
Princeton 12
Boston 11
Izmir 10
Rome 10
Brussels 9
Cattolica 9
Munich 9
Fairfield 8
Singapore 8
University Park 8
Beijing 7
Leawood 7
Nanchang 7
Redmond 7
Woodbridge 7
Redwood City 6
Seattle 6
Augusta 5
Hebei 5
Lancaster 5
Mountain View 5
Cambridge 4
Shenyang 4
Tianjin 4
Bregano 3
Changsha 3
Hangzhou 3
Jiaxing 3
Los Angeles 3
Paris 3
Pescara 3
Sacramento 3
Shanghai 3
Vienna 3
Angeles City 2
Ardabil 2
Boardman 2
Bologna 2
Budapest 2
Frankfurt am Main 2
Fremont 2
Hefei 2
Hong Kong 2
Indiana 2
Kuala Lumpur 2
London 2
Norwalk 2
Pune 2
Riverside 2
Santiago De Compostela 2
Simi Valley 2
Vietri Sul Mare 2
Vigodarzere 2
Washington 2
Zhengzhou 2
Amsterdam 1
Andover 1
Aradeo 1
Baghdad 1
Bern 1
Brno 1
Buenos Aires 1
Chicago 1
Chiswick 1
Civitavecchia 1
Costa Mesa 1
Delhi 1
Edinburgh 1
Essen 1
Falkenstein 1
Florence 1
Frascati 1
Fuzhou 1
Genova 1
Gravina di Catania 1
Guangzhou 1
Guatemala City 1
Harbin 1
Herndon 1
Hounslow 1
Jinan 1
Jinhua 1
Totale 942
Nome #
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT 140
Assessment of insulin resistance in lean women with polycystic ovary syndrome. 139
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 104
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 85
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 80
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 79
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 75
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 72
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 72
The Performance of Serum Antimullerian Hormone and Antral Follicle Count in Predicting the Ovarian Response in Intrauterine Insemination 67
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action 67
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study 65
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function 64
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 62
Circulating irisin levels in functional hypothalamic amenorrhea: a new bone damage index? A pilot study. 60
Hysterosalpingo-contrast-sonography (HyCoSy) in the assessment of tubal patency in endometriosis patients 55
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 53
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: A RCT 51
Alpha-Lipoic Acid May Improve the Clinical, Endocrine and Metabolic Features of Polycystic Ovary Syndrome through an Insulin-Sensitizing Effect and an Antioxidant Action 49
Thyroid Stimulating Hormone (TSH) and Human Corpus Luteum: A Possible Contribution to Reproductive Process 49
"Hormone of darkness" and human reproductive process: direct regulatory role of melatonin in human corpus luteum 48
Psoriasis and polycystic ovary syndrome: A new link in different phenotypes 47
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 46
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 42
Insulin-sensitizing effect and antioxidant action of alpha lipoic acid in oligomenorrheic women with polycystic ovary syndrome 22
Totale 1.693
Categoria #
all - tutte 6.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201937 0 0 0 0 0 0 0 0 0 18 17 2
2019/2020199 40 16 4 6 13 13 30 4 10 8 36 19
2020/2021143 6 15 6 16 12 10 19 1 17 5 27 9
2021/2022213 12 12 3 10 13 6 4 43 7 10 45 48
2022/2023589 69 86 38 99 25 78 25 40 84 9 28 8
2023/2024257 5 83 7 9 16 77 37 7 6 10 0 0
Totale 1.693